These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8706954)
1. Advantages and disadvantages of estrogen treatment by transdermal or oral administration. Rozenbaum H Eur J Obstet Gynecol Reprod Biol; 1996 Mar; 65(1):33-7. PubMed ID: 8706954 [No Abstract] [Full Text] [Related]
2. Transdermal hormone therapy and the risk of stroke and venous thrombosis. Speroff L Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199 [TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics and efficacy of different estrogens are not equivalent. Ansbacher R Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470 [TBL] [Abstract][Full Text] [Related]
4. The menopause, hormone replacement, and cardiovascular disease: the epidemiologic evidence. Barrett-Connor E Maturitas; 1996 Mar; 23(2):227-34. PubMed ID: 8735360 [No Abstract] [Full Text] [Related]
5. Addendum: Transdermal estrogen (Med Lett Drugs Ther 2012;54:41). Med Lett Drugs Ther; 2012 Jul; 54(1394):56. PubMed ID: 22826825 [No Abstract] [Full Text] [Related]
6. Kinetics and pharmacology of estrogens in pre- and postmenopausal women. Anderson F Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():55-64. PubMed ID: 8499960 [TBL] [Abstract][Full Text] [Related]
8. [Menopause in women--hormonal replacement therapy]. Kulikowski M; Tomaszewska I Pol Tyg Lek; 1995 Nov; 50(44-47):5-9. PubMed ID: 8643429 [No Abstract] [Full Text] [Related]
9. Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women? Clarkson TB; Karas RH Menopause; 2007; 14(6):963-7. PubMed ID: 17909452 [No Abstract] [Full Text] [Related]
10. Is there a place for postmenopausal hormone therapy use in women with lupus? Gompel A; Piette JC Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529 [TBL] [Abstract][Full Text] [Related]
11. The menopause: benefits and risks of hormone replacement therapy. Gambrell RD Compr Ther; 1994; 20(10):580-5. PubMed ID: 7859441 [No Abstract] [Full Text] [Related]
12. Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy. Simon JA; Laliberté F; Duh MS; Pilon D; Kahler KH; Nyirady J; Davis PJ; Lefebvre P Menopause; 2016 Jun; 23(6):600-10. PubMed ID: 26953655 [TBL] [Abstract][Full Text] [Related]
13. The Effect of Transdermal Estrogen Patch Use on Cardiovascular Outcomes: A Systematic Review. Bezwada P; Shaikh A; Misra D J Womens Health (Larchmt); 2017 Dec; 26(12):1319-1325. PubMed ID: 28622476 [TBL] [Abstract][Full Text] [Related]
14. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration. Połać I; Borowiecka M; Wilamowska A; Nowak P Gynecol Endocrinol; 2013 Feb; 29(2):165-8. PubMed ID: 23116237 [TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy: estrogen after menopause. Gibaldi M Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594 [No Abstract] [Full Text] [Related]
16. Hormone-replacement therapy. Weighing the benefits and risks. Harv Health Lett; 1997 Oct; 22(12):1-3. PubMed ID: 9674386 [No Abstract] [Full Text] [Related]
17. [Estrogen replacement therapy and cardiovascular disease in postmenopausal women. II. Mechanisms of action of estrogens]. Sitruk-Ware R Presse Med; 1990 Sep; 19(29):1364-7. PubMed ID: 2146610 [TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and the menopause. Australian Menopause Society. MacLennan AH Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437 [No Abstract] [Full Text] [Related]
19. Are all estrogens created equal? A review of oral vs. transdermal therapy. Goodman MP J Womens Health (Larchmt); 2012 Feb; 21(2):161-9. PubMed ID: 22011208 [TBL] [Abstract][Full Text] [Related]
20. Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation. Lobo RA; Clarkson TB Menopause; 2011 Feb; 18(2):237-40. PubMed ID: 21341399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]